As clinical trials expand and regulations evolve, Ricky Lakhani at PHARMASEAL speaks to ICT about …

Engility CTMS has been designed and developed utilising agile engineering practices with extensive automation to ensure that validation assets can be generated with higher accuracy and quality utilising the PHARMASEAL continuous validation framework.
Our automated continuous validation framework reduces the time it takes to validate the system. Whilst validation is required in a regulated industry, our approach allows us to increase the pace of innovation in a controlled way. Innovative CTMS systems that are engineered for change offer extensive automation to deliver new features in a regulated industry, faster than current products. Intuitive systems that utilize flexible cloud architecture allow biopharmaceutical and medical device companies of all sizes to leverage affordable enterprise technology to fit their individual organisation model, expediating clinical development.
PHARMASEAL was founded in 2016 by a team of industry leaders who share a vision to create smarter technologies and innovative products for the improvement of human health.
The company’s first product Engility CTMS simplifies the management and control of clinical trials for biopharmaceutical and medical device companies. Engility CTMS utilises advanced engineering offering enterprise management with rapid deployment, an intuitive user interface and interoperability with other eClinical applications to optimise trial governance and oversight.
As clinical trials expand and regulations evolve, Ricky Lakhani at PHARMASEAL speaks to ICT about …
It’s that time of year where the last half-term holidays have ended (at least in the UK), and …
Although Agile software development has its origins in the 70s (and probably earlier), I remember …
Celebrating its 11th successful year, SCOPE Summit 2020 takes place February 18-21 in Orlando, FL. …
For the 28th year, SOCRA will …